Endpoints News May 15, 2026 Aardvark's next move after clinical hold; Alumis' verdict on Acelyrin asset
Endpoints News May 15, 2026 M&A isn’t just for big pharma. Mid-size companies are stepping up deal hunts
Endpoints News May 15, 2026 Andrea Pfeifer ends 23-year reign at AC Immune; Acadia's top R&D exec announces retirement
Endpoints News May 15, 2026 #ASGCT26: A Zillow-like marketplace for abandoned gene therapies goes live
Endpoints News May 14, 2026 MacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attack
Endpoints News May 14, 2026 Biogen's anti-tau Alzheimer's drug misses Phase 2 goal, but claims signs of efficacy